Effects of Psilocybin in Major Depressive Disorder
Status:
Completed
Trial end date:
2020-12-02
Target enrollment:
Participant gender:
Summary
The proposed pilot study will assess whether people with major depressive disorder experience
psychological and behavioral benefits and/or harms from psilocybin. This study will
investigate acute and persisting effects of psilocybin on depressive symptoms and other
moods, attitudes, and behaviors. The primary hypothesis is that psilocybin will lead to rapid
and sustained antidepressant response, as measured with standard depression rating scales.